Profound misregulation of muscle-specific gene expression in facioscapulohumeral muscular dystrophy.

Facioscapulohumeral muscular dystrophy (FSHD) is a neuromuscular disorder characterized by an insidious onset and progressive course. The disease has a frequency of about 1 in 20,000 and is transmitted in an autosomal dominant fashion with almost complete penetrance. Deletion of an integral number of tandemly arrayed 3.3-kb repeat units (D4Z4) on chromosome 4q35 is associated with FSHD but otherwise the molecular basis of the disease and its pathophysiology remain obscure. Comparison of mRNA populations between appropriate cell types can facilitate identification of genes relevant to a particular biological or pathological process. In this report, we have compared mRNA populations of FSHD and normal muscle. Unexpectedly, the dystrophic muscle displayed profound alterations in gene expression characterized by severe underexpression or overexpression of specific mRNAs. Intriguingly, many of the deregulated mRNAs are muscle specific. Our results suggest that a global misregulation of gene expression is the underlying basis for FSHD, distinguishing it from other forms of muscular dystrophy. The experimental approach used here is applicable to any genetic disorder whose pathogenic mechanism is incompletely understood.

[1]  M. Wigler,et al.  Cloning the differences between two complex genomes , 1993, Science.

[2]  H. Willard,et al.  Epigenetic regulation of gene expression: the effect of altered chromatin structure from yeast to mammals. , 1995, Human molecular genetics.

[3]  J. Mendell,et al.  Linkage analyses of five chromosome 4 markers localizes the facioscapulohumeral muscular dystrophy (FSHD) gene to distal 4q35. , 1992, American journal of human genetics.

[4]  F. Sanger,et al.  DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[5]  K. Buetow,et al.  Linkage localization of facioscapulohumeral muscular dystrophy (FSHD) in 4q35. , 1992, American journal of human genetics.

[6]  P. Harper,et al.  Estimation of age dependent penetrance in facioscapulohumeral muscular dystrophy by minimising ascertainment bias. , 1989, Journal of Medical Genetics.

[7]  R. Weigel,et al.  Differential screening and suppression subtractive hybridization identified genes differentially expressed in an estrogen receptor-positive breast carcinoma cell line. , 1998, Nucleic acids research.

[8]  Bruce Stillman,et al.  Nucleosomal DNA regulates the core-histone-binding subunit of the human Hat1 acetyltransferase , 1998, Current Biology.

[9]  M. Memmi,et al.  Identical de novo mutation at the D4F104S1 locus in monozygotic male twins affected by facioscapulohumeral muscular dystrophy (FSHD) with different clinical expression. , 1998, Journal of medical genetics.

[10]  A. Gewirtz,et al.  A method for identifying differentially expressed genes in rare populations of primary human hematopoietic cells , 1999, Leukemia.

[11]  C. Wijmenga,et al.  Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy , 1992, Nature genetics.

[12]  S. Kuhlman,et al.  A screen for genes induced in the suprachiasmatic nucleus by light. , 1998, Science.

[13]  R. Lyle,et al.  The FSHD-associated repeat, D4Z4, is a member of a dispersed family of homeobox-containing repeats, subsets of which are clustered on the short arms of the acrocentric chromosomes. , 1995, Genomics.

[14]  J. Gilbert,et al.  Linkage studies in facioscapulohumeral muscular dystrophy (FSHD). , 1992, American journal of human genetics.

[15]  J. Hoeijmakers,et al.  Inactivation of the HR6B Ubiquitin-Conjugating DNA Repair Enzyme in Mice Causes Male Sterility Associated with Chromatin Modification , 1996, Cell.

[16]  Aaron P. Campbell,et al.  Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[17]  M. Pericak-Vance,et al.  Regional mapping of facioscapulohumeral muscular dystrophy gene on 4q35: combined analysis of an international consortium. , 1992, American journal of human genetics.

[18]  A. Krumm,et al.  HMG17 is a chromatin-specific transcriptional coactivator that increases the efficiency of transcription initiation. , 1995, Genes & development.

[19]  C. Bucana,et al.  Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C. , 1997, Science.

[20]  R. Moss,et al.  Improved methodology for analysis and quantitation of proteins on one-dimensional silver-stained slab gels. , 1983, Analytical biochemistry.

[21]  J E Hewitt,et al.  Analysis of the tandem repeat locus D4Z4 associated with facioscapulohumeral muscular dystrophy. , 1994, Human molecular genetics.

[22]  K. Goto,et al.  Characterization of a tandemly repeated 3.3‐kb Kpnl unit in the facioscapulohumeral muscular dystrophy (FSHD) gene region on chromosome 4q35 , 1995, Muscle & nerve. Supplement.

[23]  R. Paro,et al.  Spreading the silence: epigenetic transcriptional regulation during Drosophila development. , 1994, Developmental Genetics.

[24]  E. Myers,et al.  Basic local alignment search tool. , 1990, Journal of molecular biology.